AMXI-5001
Showing 1 - 5 of 5
Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,
Recruiting
- Advanced Malignant Neoplasm
- +5 more
- AMXI-5001:Dose Escalation Phase I
- AMXI-5001:Dose Expansion Phase II
-
Phoenix, Arizona
- +7 more
Jul 18, 2022
Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)
Recruiting
- Alzheimer Disease
- GB-5001A
- +2 more
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Nov 17, 2023
Acute Myeloid Leukemia Trial in United Kingdom, United States (Arm 1: NTLA-5001, Arm 2: NTLA-5001)
Terminated
- Acute Myeloid Leukemia
- Arm 1: NTLA-5001
- Arm 2: NTLA-5001
-
Los Angeles, California
- +9 more
Oct 13, 2022
Acute Myocardial Infarction, CHF, ST-Elevation Myocardial Infarction Trial in Worldwide (IK-5001, Saline Solution)
Completed
- Acute Myocardial Infarction
- +2 more
- IK-5001
- Saline Solution
-
Birmingham, Alabama
- +81 more
Aug 9, 2022
Respiratory Tract Diseases Trial in Great Lakes, Fort Jackson (DR-5001, Placebo)
Completed
- Respiratory Tract Diseases
- DR-5001
- Placebo
-
Great Lakes, Illinois
- +1 more
Mar 9, 2017